Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents
Author(s) -
Jennifer Yu,
Roxana Mehran,
Usman Baber,
SzeYuan Ooi,
Bernhard Witzenbichler,
Giora Weisz,
Michael J. Rinaldi,
FranzJosef Neumann,
D. Christopher Metzger,
Timothy D. Henry,
David A. Cox,
Peter L. Duffy,
Ernest L. Mazzaferri,
Bruce R. Brodie,
Thomas Stuckey,
Akiko Maehara,
Ke Xu,
Ori BenYehuda,
Ajay J. Kirtane,
Gregg W. Stone
Publication year - 2017
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.116.003577
Subject(s) - medicine , percutaneous coronary intervention , drug , cardiology , drug eluting stent , percutaneous , myocardial infarction , pharmacology
Sex differences in the outcomes after percutaneous coronary intervention with drug-eluting stents and in the response to clopidogrel therapy have been reported; however, the differential risk of high platelet reactivity (HPR) on clopidogrel in women versus men is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom